| 000 | 01473 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250514224417.0 | ||
| 264 | 0 | _c20050926 | |
| 008 | 200509s 0 0 eng d | ||
| 022 | _a0041-1345 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2004.12.010 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBoratyńska, M | |
| 245 | 0 | 0 |
_aSirolimus delays recovery from posttransplant renal failure in kidney graft recipients. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _cMar 2005 |
||
| 300 |
_a839-42 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCadaver |
| 650 | 0 | 4 |
_aCreatinine _xblood |
| 650 | 0 | 4 |
_aCyclosporine _xtherapeutic use |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGraft Rejection _xepidemiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKidney Transplantation _ximmunology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPrednisone _xtherapeutic use |
| 650 | 0 | 4 |
_aSirolimus _xadverse effects |
| 650 | 0 | 4 | _aTissue Donors |
| 650 | 0 | 4 | _aTreatment Failure |
| 650 | 0 | 4 |
_aWound Healing _xdrug effects |
| 700 | 1 | _aBanasik, M | |
| 700 | 1 | _aPatrzalek, D | |
| 700 | 1 | _aSzyber, P | |
| 700 | 1 | _aKlinger, M | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 37 _gno. 2 _gp. 839-42 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2004.12.010 _zAvailable from publisher's website |
| 999 |
_c15516058 _d15516058 |
||